title: Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.
authors.affiliation: Division of Cardiology, Sunnybrook Medical Centre, Toronto, Ont.
authors.forename: M G
authors.initials: MG
authors.lastname: Myers
authors.forename: S G
authors.initials: SG
authors.lastname: Carruthers
authors.forename: F H
authors.initials: FH
authors.lastname: Leenen
authors.forename: R B
authors.initials: RB
authors.lastname: Haynes
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002170:Canada; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D011247:Pregnancy; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors